Follow the NeuPath Health Inc. share price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are listed on CA CA, under the authority of SEDI. Market capitalisation: €36.5m. The latest transaction was filed on 2 July 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: NeuPath Health Inc.. Every trade is accessible without an account.
28
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,428 of 27,989 companies
36.3
score / 100
Value
47
Quality
26
FCF yld9.2%
Earn yld-2.1%
EV/EBITDA15.2x
ROE1.4%
Gross mgn19%
Net mgn-0.8%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
10,000 shares@ CA$0.5517.4% of flowCommon SharesTSXSEDI:4728873
25 of 28 declarations
About NeuPath Health Inc.
NeuPath Health Inc. is a Canadian healthcare company focused on the treatment of chronic pain. It primarily operates on the Toronto Stock Exchange (XTSE).